Fingolimod 0.5 MG Oral Capsule — RxCUI 1012895
RxNorm drug concept · Semantic clinical drug
RxCUI 1012895
Semantic clinical drug · SCD
● Current RxNorm concept 22 FDA products
47 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1012895
Official nameFingolimod 0.5 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asfingolimod 500 MCG Oral Capsule; fingolimod 0.5 MG (as fingolimod HCl 0.56 MG) Oral Capsule
FDA products mapped22
Package NDCs mapped47
Reported Medicaid activity (SDUD)6,907 prescriptions · 35 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Fingolimod: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It treats relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease. It is approved for pe...
- Take it by mouth once a day, with or without food. If you have Tascenso ODT, place it on your tongue and let it dissolve. Follow your prescriber's directions exactly.
- Fingolimod can slow your heart rate and cause heart block, mostly in the first 6 hours. We check your pulse, blood pressure and ECG. Some people need overnight monitoring. This may...
- Why do I have to be watched after the first dose?
🕸️ Concept Web — How Fingolimod 0.5 MG Oral Capsule Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Fingolimod 0.5 MG Oral Capsule
RxCUI 1012895 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Fingolimod
1012892IN
-
Fingolimod
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Gilenya
1012896BN
-
Gilenya
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Fingolimod Oral Capsule
1012894SCDF -
Fingolimod Oral Product
1165017SCDG -
Fingolimod Pill
1165018SCDG -
Fingolimod Oral Capsule [Gilenya]
1012898SBDF -
Gilenya Oral Product
1170524SBDG -
Gilenya Pill
1170525SBDG -
Oral Capsule
316965DF -
Oral Product
1151131DFG - +1 more in this family
-
Fingolimod Oral Capsule
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Fingolimod 0.5 MG
1012893SCDC -
Fingolimod 0.5 MG Oral Capsule [Gilenya]
1012899SBD -
Fingolimod 0.5 MG [Gilenya]
1012897SBDC
-
Fingolimod 0.5 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Fingolimod 0.5 MG
SCDC · 1012893 -
Fingolimod Oral Capsule
SCDF · 1012894 -
Fingolimod Oral Product
SCDG · 1165017 -
Fingolimod Pill
SCDG · 1165018
Brand-Name Concepts
-
Fingolimod 0.5 MG Oral Capsule [Gilenya]
SBD · 1012899 -
Fingolimod 0.5 MG [Gilenya]
SBDC · 1012897 -
Fingolimod Oral Capsule [Gilenya]
SBDF · 1012898 -
Gilenya Oral Product
SBDG · 1170524 -
Gilenya Pill
SBDG · 1170525 -
Gilenya
BN · 1012896
📦 FDA Products & Package NDCs
22 products · 47 package NDCs
47 package NDCs map to RxCUI 1012895 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00078-0607-15 | 30 CAPSULE in 1 BOTTLE (0078-0607-15) | Gilenya | Novartis Pharmaceuticals Corporation | 2010-09-21 |
| 00078-0965-89 | 7 CAPSULE in 1 CARTON (0078-0965-89) | Gilenya | Novartis Pharmaceuticals Corporation | 2018-05-11 |
| 00480-7820-56 | 30 CAPSULE in 1 BOTTLE (0480-7820-56) | Fingolimod | Teva Pharmaceuticals, Inc. | 2024-02-14 |
| 16729-0342-10 | 30 CAPSULE in 1 BOTTLE (16729-342-10) | FINGOLIMOD HYDROCHLORIDE | Accord Healthcare Inc. | 2022-10-18 |
| 31722-0889-30 | 30 CAPSULE in 1 BOTTLE (31722-889-30) | Fingolimod | Camber Pharmaceuticals, Inc. | 2019-09-27 |
| 42291-0048-30 | 30 CAPSULE in 1 BOTTLE (42291-048-30) | Fingolimod | AvKARE | 2024-02-15 |
| 43547-0003-03 | 30 CAPSULE in 1 BOTTLE (43547-003-03) | FINGOLIMOD | Solco Healthcare US, LLC | 2021-10-26 |
| 43547-0003-09 | 90 CAPSULE in 1 BOTTLE (43547-003-09) | FINGOLIMOD | Solco Healthcare US, LLC | 2021-10-26 |
| 43598-0285-30 | 30 CAPSULE in 1 BOTTLE (43598-285-30) | Fingolimod | Dr. Reddy's Laboratories Inc | 2022-10-11 |
| 43598-0285-31 | 3 BLISTER PACK in 1 CARTON (43598-285-31) / 10 CAPSULE in 1... | Fingolimod | Dr. Reddy's Laboratories Inc | 2022-10-11 |
| 43598-0285-70 | 1 BLISTER PACK in 1 CARTON (43598-285-70) / 7 CAPSULE in 1... | Fingolimod | Dr. Reddy's Laboratories Inc | 2022-10-11 |
| 46708-0228-10 | 100 BLISTER PACK in 1 CARTON (46708-228-10) / 10 CAPSULE in... | Fingolimod | Alembic Pharmaceuticals Limited | 2026-04-28 |
| 46708-0228-30 | 30 CAPSULE in 1 BOTTLE (46708-228-30) | Fingolimod | Alembic Pharmaceuticals Limited | 2026-04-28 |
| 60505-4332-03 | 30 CAPSULE in 1 BOTTLE (60505-4332-3) | Fingolimod | Apotex Corp. | 2022-10-18 |
| 62332-0228-10 | 100 BLISTER PACK in 1 CARTON (62332-228-10) / 10 CAPSULE in... | Fingolimod | Alembic Pharmaceuticals Inc. | 2026-04-28 |
| 62332-0228-30 | 30 CAPSULE in 1 BOTTLE (62332-228-30) | Fingolimod | Alembic Pharmaceuticals Inc. | 2026-04-28 |
| 62756-0064-59 | 1 BLISTER PACK in 1 CARTON (62756-064-59) / 7 CAPSULE in 1... | Fingolimod | Sun Pharmaceutical Industries, Inc. | 2022-10-25 |
| 62756-0064-81 | 90 CAPSULE in 1 BOTTLE (62756-064-81) | Fingolimod | Sun Pharmaceutical Industries, Inc. | 2022-10-25 |
| 62756-0064-83 | 30 CAPSULE in 1 BOTTLE (62756-064-83) | Fingolimod | Sun Pharmaceutical Industries, Inc. | 2022-10-25 |
| 62756-0064-96 | 2 BLISTER PACK in 1 CARTON (62756-064-96) / 14 CAPSULE in 1... | Fingolimod | Sun Pharmaceutical Industries, Inc. | 2022-10-25 |
| 64980-0449-03 | 30 CAPSULE in 1 BOTTLE (64980-449-03) | fingolimod | Rising Pharma Holdings, Inc. | 2023-09-04 |
| 65862-0952-07 | 1 BLISTER PACK in 1 CARTON (65862-952-07) / 7 CAPSULE in 1... | FINGOLIMOD | Aurobindo Pharma Limited | 2024-02-28 |
| 65862-0952-28 | 4 BLISTER PACK in 1 CARTON (65862-952-28) / 7 CAPSULE in 1... | FINGOLIMOD | Aurobindo Pharma Limited | 2024-02-28 |
| 65862-0952-30 | 30 CAPSULE in 1 BOTTLE (65862-952-30) | FINGOLIMOD | Aurobindo Pharma Limited | 2024-02-28 |
| 67877-0476-30 | 30 CAPSULE in 1 BOTTLE (67877-476-30) | Fingolimod | Ascend Laboratories, LLC | 2022-09-21 |
| 67877-0476-32 | 7 BLISTER PACK in 1 CARTON (67877-476-32) / 7 CAPSULE in 1... | Fingolimod | Ascend Laboratories, LLC | 2022-09-21 |
| 67877-0476-33 | 10 BLISTER PACK in 1 CARTON (67877-476-33) / 10 CAPSULE in... | Fingolimod | Ascend Laboratories, LLC | 2022-09-21 |
| 67877-0476-56 | 28 CAPSULE in 1 BOTTLE (67877-476-56) | Fingolimod | Ascend Laboratories, LLC | 2022-09-21 |
| 67877-0476-58 | 28 BLISTER PACK in 1 CARTON (67877-476-58) / 14 CAPSULE in... | Fingolimod | Ascend Laboratories, LLC | 2022-09-21 |
| 68382-0912-01 | 100 CAPSULE in 1 BOTTLE (68382-912-01) | Fingolimod | Zydus Pharmaceuticals USA Inc. | 2022-10-11 |
| 68382-0912-06 | 30 CAPSULE in 1 BOTTLE (68382-912-06) | Fingolimod | Zydus Pharmaceuticals USA Inc. | 2022-10-11 |
| 68382-0912-16 | 90 CAPSULE in 1 BOTTLE (68382-912-16) | Fingolimod | Zydus Pharmaceuticals USA Inc. | 2022-10-11 |
| 68382-0912-69 | 1 BLISTER PACK in 1 CARTON (68382-912-69) / 7 CAPSULE in 1... | Fingolimod | Zydus Pharmaceuticals USA Inc. | 2022-10-11 |
| 68382-0912-70 | 4 BLISTER PACK in 1 CARTON (68382-912-70) / 7 CAPSULE in 1... | Fingolimod | Zydus Pharmaceuticals USA Inc. | 2022-10-11 |
| 68462-0166-07 | 7 BLISTER PACK in 1 CARTON (68462-166-07) / 7 CAPSULE in 1... | fingolimod | Glenmark Pharmaceuticals Inc., USA | 2022-09-28 |
| 68462-0166-15 | 28 CARTON in 1 CARTON (68462-166-15) / 14 BLISTER PACK in 1... | fingolimod | Glenmark Pharmaceuticals Inc., USA | 2022-09-28 |
| 68462-0166-30 | 30 CAPSULE in 1 BOTTLE (68462-166-30) | fingolimod | Glenmark Pharmaceuticals Inc., USA | 2022-09-28 |
| 70377-0019-11 | 30 CAPSULE in 1 BOTTLE (70377-019-11) | FINGOLIMOD | Biocon Pharma Inc. | 2024-03-28 |
| 70377-0019-21 | 28 CAPSULE in 1 CARTON (70377-019-21) | FINGOLIMOD | Biocon Pharma Inc. | 2024-03-28 |
| 70771-1603-01 | 100 CAPSULE in 1 BOTTLE (70771-1603-1) | Fingolimod | Zydus Lifesciences Limited | 2022-10-11 |
| 70771-1603-03 | 30 CAPSULE in 1 BOTTLE (70771-1603-3) | Fingolimod | Zydus Lifesciences Limited | 2022-10-11 |
| 70771-1603-07 | 1 BLISTER PACK in 1 CARTON (70771-1603-7) / 7 CAPSULE in 1... | Fingolimod | Zydus Lifesciences Limited | 2022-10-11 |
| 70771-1603-08 | 4 BLISTER PACK in 1 CARTON (70771-1603-8) / 7 CAPSULE in 1... | Fingolimod | Zydus Lifesciences Limited | 2022-10-11 |
| 70771-1603-09 | 90 CAPSULE in 1 BOTTLE (70771-1603-9) | Fingolimod | Zydus Lifesciences Limited | 2022-10-11 |
| 72865-0257-30 | 30 CAPSULE in 1 BOTTLE (72865-257-30) | Fingolimod | XLCare Pharmaceuticals Inc. | 2024-06-17 |
| 82009-0143-30 | 30 CAPSULE in 1 BOTTLE (82009-143-30) | FINGOLIMOD | Quallent Pharmaceuticals Health LLC | 2024-03-28 |
| 82249-0385-30 | 30 CAPSULE in 1 BOTTLE (82249-385-30) | Fingolimod | CivicaScript LLC | 2026-06-01 |
Observed labelers:
Ascend Laboratories, LLC (5) ·
Zydus Lifesciences Limited (5) ·
Zydus Pharmaceuticals USA Inc. (5) ·
Sun Pharmaceutical Industries, Inc. (4) ·
Aurobindo Pharma Limited (3) ·
Dr. Reddy's Laboratories Inc (3)
· +15 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.